News | Stent Grafts | August 13, 2015

Medtronic Completes First European Cases With Endurant Evo AAA Stent Graft System

Investigational medical device poised to expand applicability of minimally invasive alternative to open surgical repair

Medtronic, Endurant Evo AAA, stent graft system, first European cases

August 13, 2015 — Medtronic plc announced that the first two European patient cases with the Endurant Evo AAA stent graft system were successfully performed at the Erasmus Medical Center in Rotterdam, Netherlands. Both procedures were performed by Prof. Hence Verhagen, M.D., Ph.D., chief of vascular surgery, and his team.

Medtronic began a clinical study in April 2015 to evaluate the safety and effectiveness of the Endurant Evo AAA stent graft system, an investigational medical device designed to expand the applicability of a minimally invasive alternative to open surgical repair for the treatment of abdominal aortic aneurysms.

The first patient was 70 years old and had a 52mm aneurysm. The implant was done with a percutaneous approach thanks to the device’s low profile. The case was successful, with no endoleaks at the final control. The second patient was 74 years old and had a 55mm aneurysm. All the devices were correctly positioned thanks to the 3-piece approach and in-situ sizing capabilities, after a planned coiling and overstenting of one hypogastric artery. The precise deployment resulted in procedural success with no endoleaks at the final imaging.

“The Endurant Evo AAA stent graft system has the potential to improve the treatment for abdominal aortic aneurysms. The system is well designed and the simplified procedure helped to reduce the procedure time,” said Verhagen.

The study will enroll 140 patients with infrarenal abdominal aortic or aortoiliac aneurysms at up to 30 sites in Europe and the United States. All study patients will be treated with the Endurant Evo AAA stent graft system. The study will evaluate safety and efficacy of the new stent graft system. The primary effectiveness objective is to evaluate successful delivery and deployment of the Endurant Evo AAA stent graft system with successful removal of the delivery system during the index procedure. Safety endpoint is defined as the proportion of subjects free from a major adverse event within 30 days post-implantation;

Clinical evidence from the study will be used to seek regulatory approvals required to commercialize the Endurant Evo AAA stent graft system in European, U.S. and other markets around the world.

For more information: www.medtronic.com

Related Content

Obese Patients Have More Post-Op Problems Following AAA Repair
News | Endovascular Aortic Repair | November 21, 2018
New research in the December edition of the Journal of Vascular Surgery suggests significant increase in morbidities in...
FDA Classifies Previous Endologix AFX Safety Notice as Class I Recall
News | Endovascular Aortic Repair | October 08, 2018
Endologix Inc. received notice that the U.S. Food and Drug Administration (FDA) has classified a voluntary recall...
The Gore TAG stent graft used in TEVAR aortic repair procedures for aneurysms.

The Gore TAG stent graft used for endovascular aortic aneurysm repair procedures.

Feature | Endovascular Aortic Repair | February 05, 2018 | Andrei Churyla, M.D., S. Chris Malaisrie, M.D.
Here are several considerations for physicians when choosing...
Endologix Receives IDE Approval for EVAS2 Confirmatory Clinical Study
News | Endovascular Aortic Repair | October 19, 2017
Endologix Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair | May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study
News | Endovascular Aortic Repair | April 05, 2017
Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms...
Beaumont Hospital, Michigan, endovascular aortic repair, EVAR, conscious sedation
News | Endovascular Aortic Repair | July 08, 2016
Kirk Schoenherr, 56, of Clinton Township, Mich., recently became just the second patient at Beaumont Hospital, Royal...
Aptus Endosystems, Medtronic, acquisition, Heli-FX, Thoracic EndoAnchor, EVAR

Heli-FX image courtesy of Aptus Endosystems

News | Endovascular Aortic Repair | July 02, 2015
Medtronic plc announced it has acquired the assets of Aptus Endosystems Inc., a privately held medical device company...
Overlay Init